Use in Pregnancy: Results from a large prospective epidemiological study and from world-wide post marketing experience indicate no adverse effects of inhaled budesonide during pregnancy on the health of the foetus new born child.
As with other drugs the administration of budesonide during pregnancy requires that the benefits for the mother be weighed against the risks for the foetus. Inhaled glucocorticosteroids should be considered for the treatment of asthma because of the lower systemic effects compared with oral glucocorticosteroids required to achieve similar pulmonary responses.
Use in Lactation: Budesonide is excreted in breast milk. However, at therapeutic doses of Pulmicort Nebuliser Suspension no effects on the suckling child are anticipated. Pulmicort Nebuliser Suspension can be used during breast feeding.